Vanguard Personalized Indexing Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
15,331
+3,206
+26% +$281K 0.01% 831
2026
Q1
$1.1M Buy
12,125
+2,270
+23% +$208K 0.01% 883
2025
Q4
$886K Sell
9,855
-5,918
-38% -$561K 0.01% 978
2025
Q3
$1.55M Buy
15,773
+3,579
+29% +$355K 0.02% 696
2025
Q2
$1.11M Sell
12,194
-3,499
-22% -$338K 0.01% 827
2025
Q1
$1.78M Sell
15,693
-4,289
-21% -$459K 0.03% 534
2024
Q4
$2.11M Buy
19,982
+5,108
+34% +$548K 0.03% 465
2024
Q3
$1.61M Sell
14,874
-315
-2% -$34.4K 0.03% 551
2024
Q2
$1.62M Sell
15,189
-2,080
-12% -$245K 0.03% 481
2024
Q1
$2.28M Buy
17,269
+1,908
+12% +$238K 0.05% 356
2023
Q4
$1.87M Buy
15,361
+4,506
+42% +$503K 0.05% 363
2023
Q3
$1.22M Buy
10,855
+1,065
+11% +$135K 0.04% 474
2023
Q2
$1.43M Buy
9,790
+1,246
+15% +$169K 0.04% 417
2023
Q1
$1.1M Sell
8,544
-1,119
-12% -$140K 0.04% 480
2022
Q4
$1.23M Buy
9,663
+2,511
+35% +$291K 0.05% 429
2022
Q3
$748K Buy
7,152
+2,303
+47% +$253K 0.03% 610
2022
Q2
$509K Sell
4,849
-665
-12% -$78.9K 0.02% 818
2022
Q1
$705K Buy
5,514
+708
+15% +$85.3K 0.03% 646
2021
Q4
$593K Buy
4,806
+1,110
+30% +$145K 0.03% 636
2021
Q3
$525K Buy
3,696
+424
+13% +$62.4K 0.05% 485
2021
Q2
$511K Buy
3,272
+447
+16% +$72.4K 0.05% 468
2021
Q1
$439K Buy
2,825
+1,142
+68% +$177K 0.07% 359
2020
Q4
$252K Buy
+1,683
New +$238K 0.05% 431

Other funds holding ZBH

Vanguard Personalized Indexing Management's ZBH Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Zimmer Biomet (ZBH) stake by 26% in Q2 2026, buying an estimated $281K and bringing the position to 15,331 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #831.

Vanguard Personalized Indexing Management first reported a position in ZBH in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.28M in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Vanguard Personalized Indexing Management held 15,331 shares of Zimmer Biomet worth $1.32M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 3,206 Zimmer Biomet shares in Q2 2026, an estimated $281K.
  • Zimmer Biomet made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #831 holding.
  • Vanguard Personalized Indexing Management first reported a position in Zimmer Biomet in Q4 2020 and has held it in 23 quarters since.
  • Vanguard Personalized Indexing Management's Zimmer Biomet position peaked at $2.28M in Q1 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.